ConductScience.org, home

Paper684036

Multicompartmental analysis of serum, urine and bile concentrations of rifampicin and desacetyl-rifampicin in subjects treated for one week.

Acocella G and 2 others. Pharmacol Res Commun, 1978. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Multicompartmental analysis of serum, urine and bile concentrations of rifampicin and desacetyl-rifampicin in subjects treated for one week. Papers, record 684036. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/684036

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multicompartmental analysis of serum, urine and bile concentrations of rifampicin and desacetyl-rifampicin in subjects treated for one week.
PubMed
Journal
Pharmacol Res Commun
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
2.01
iCite
Revised in PubMed
2019-09-18
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Acocella GG
2Mattiussi RR
3Segre GG

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
RifampinMajor topic
Bile
Chromatography, Thin Layer
Dealkylation
Female
Humans
Kinetics
Models, Biological
Time Factors

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
41787130In Silico Comparison of Rifampicin and 25-desacetyl Rifampicin-Induced PXR-Mediated CYP450 Transcriptional Response in 3D Primary Human Hepatocytes.Bull Math Biol2026https://conductscience.org/library/papers/41787130PubMed
37705216Various effects of repeated rifampin dosing on coproporphyrin levels in humans.Clin Transl Sci2023https://conductscience.org/library/papers/37705216PubMed
37324091Oral rifampicin interferes with urine dipstick tests for patients with pulmonary tuberculosis.J Thorac Dis2023https://conductscience.org/library/papers/37324091PubMed
29368402Comprehensive PBPK Model of Rifampicin for Quantitative Prediction of Complex Drug-Drug Interactions: CYP3A/2C9 Induction and OATP Inhibition Effects.CPT Pharmacometrics Syst Pharmacol2018https://conductscience.org/library/papers/29368402PubMed
26055359Pharmacokinetic Modeling and Optimal Sampling Strategies for Therapeutic Drug Monitoring of Rifampin in Patients with Tuberculosis.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/26055359PubMed
22472995Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers.Clin Pharmacol Ther2012https://conductscience.org/library/papers/22472995PubMed
18391026Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18391026PubMed
15762766Pharmacokinetic considerations in the treatment of tuberculosis in patients with renal failure.Clin Pharmacokinet2005https://conductscience.org/library/papers/15762766PubMed
6721995Rifampicin kinetics in undernutrition.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6721995PubMed
6615687Hepatic enzyme induction and leucocyte delta-aminolaevulinic acid synthase activity: studies with carbamazepine.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6615687PubMed
6391781Clinical pharmacokinetics of the antituberculosis drugs.Clin Pharmacokinet1984https://conductscience.org/library/papers/6391781PubMed
6318788Pharmacokinetic studies of cimetidine and ranitidine before and after treatment in peptic ulcer patients.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6318788PubMed
6113907Clinical implications of enzyme induction and enzyme inhibition.Clin Pharmacokinet1981https://conductscience.org/library/papers/6113907PubMed
4087830Pharmacokinetics of oral and intravenous rifampicin during chronic administration.Klin Wochenschr1985https://conductscience.org/library/papers/4087830PubMed
4027118Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4027118PubMed
2044328Nonlinear pharmacokinetics: clinical Implications.Clin Pharmacokinet1991https://conductscience.org/library/papers/2044328PubMed
346286Clinical pharmacokinetics of rifampicin.Clin Pharmacokinet1978https://conductscience.org/library/papers/346286PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/684036

GET https://conductscience.org/api/papers/v1/684036/authors